Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sublingual immunotherapy for allergic rhinitis.

D R Wilson1, L I Torres, S R Durham

  • 1Upper Respiratory Medicine, Imperial College School of Medicine at the National Heart & Lung Institute, Dovehouse Street, London, UK, SW3 6LR. duncw 99@yahoo.co.uk

The Cochrane Database of Systematic Reviews
|June 14, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using systems mapping to understand the constraints and enablers of solutions to plastic pollution.

Journal of environmental management·2024
Same author

Enhanced case management can be delivered for patients with EVD in Africa: Experience from a UK military Ebola treatment centre in Sierra Leone.

The Journal of infection·2017
Same author

Asymptomatic group A Streptococcal throat carriage in Royal Marines recruits and Young Officers.

The Journal of infection·2017
Same author

Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper.

Allergy·2017
Same author

Novel approaches and perspectives in allergen immunotherapy.

Allergy·2017
Same author

ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.

Clinical and translational allergy·2017

Sublingual immunotherapy (SLIT) effectively reduces allergic rhinitis symptoms and medication needs. This safe treatment offers an alternative to traditional methods, though further research on optimal dosing is needed.

Area of Science:

  • Allergy and Immunology
  • Pharmacology
  • Clinical Trials

Background:

  • Allergic rhinitis significantly impacts quality of life, even with standard treatments.
  • Allergen injection immunotherapy is effective but carries risks of severe reactions.
  • Sublingual immunotherapy (SLIT) has emerged as a promising alternative route for allergen immunotherapy.

Purpose of the Study:

  • To evaluate the efficacy of sublingual immunotherapy (SLIT) compared to placebo.
  • To assess reductions in allergic rhinitis symptoms and medication requirements.

Main Methods:

  • Systematic review and meta-analysis of randomized controlled trials.
  • Searched Cochrane Controlled Trials Register, MEDLINE, EMBASE, and Scisearch up to September 2002.
  • Analyzed data using Standardised Mean Differences (SMD) with a random effects model.

Related Experiment Videos

Main Results:

  • Twenty-two trials involving 979 patients were included, covering various allergens like House Dust Mite and Grass Pollen.
  • SLIT demonstrated a significant reduction in both allergic rhinitis symptoms (SMD -0.34) and medication requirements (SMD -0.43).
  • No significant benefit was observed in studies exclusively involving children, and treatment duration did not clearly correlate with increased efficacy.

Conclusions:

  • Sublingual immunotherapy (SLIT) is a safe and effective treatment for reducing allergic rhinitis symptoms and medication needs.
  • The comparative benefit of SLIT versus injection immunotherapy requires further investigation.
  • Future research should focus on optimizing allergen dosage and patient selection for SLIT.